Key Takeaway
Is AOD-9604 legal in the United States? Learn about FDA classification, compounding pharmacy access, research use legality, and athletic restrictions.
| Peptide Q&A
AOD-9604 exists in a complex legal space in the United States. It isn't FDA-approved as a drug, and its availability through compounding pharmacies has been affected by the FDA's ongoing review of bulk drug substances used in compounding. The FDA has raised concerns about certain peptides being compounded without adequate safety data, and AOD-9604 has been impacted by these regulatory actions. Purchasing AOD-9604 for research purposes remains legal, but obtaining it for personal therapeutic use requires finding current compounding regulations.
What Is AOD-9604?
AOD-9604 is a modified fragment of human growth hormone (HGH), consisting of amino acids 177 through 191 with an added tyrosine at the N-terminal. It was developed by Monash University in Australia as a potential anti-obesity treatment. The peptide is designed to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat formation) without the growth-promoting or diabetogenic effects of full-length growth hormone.
FDA Regulatory Status
AOD-9604 has never been FDA-approved for any therapeutic indication. Its regulatory process in the US includes several key developments:
View data table
| Category | Clinical Interest Score | Detail |
|---|---|---|
| BPC-157 | 88 | Tissue repair and gut healing |
| TB-500 | 82 | Injury recovery |
| Sermorelin | 78 | Growth hormone support |
| Ipamorelin | 75 | Anti-aging and recovery |
| GHK-Cu | 70 | Skin and tissue repair |
- Not an approved drug: No pharmaceutical company has successfully completed the FDA approval process for AOD-9604.
- Compounding concerns: The FDA has evaluated whether AOD-9604 meets the criteria for inclusion on the bulk drug substances list that permits compounding. The agency has expressed concerns about insufficient safety and efficacy data for compounded AOD-9604.
- Category 2 classification: The FDA placed AOD-9604 on its list of substances that raise significant safety concerns for compounding, which has restricted availability from some pharmacies.
The regulatory space for AOD-9604 continues to evolve. Check with your healthcare provider and compounding pharmacy for the most current status. where to buy AOD-9604 online
Research Use Legality
AOD-9604 can be legally purchased in the United States for research purposes. Research peptide suppliers sell AOD-9604 labeled "for research use only" or "not for human consumption." This is legal as long as the product is genuinely used for research and not for personal therapeutic administration.
From the FormBlends catalog
AOD-9604
Fat-targeting fragment without growth hormone side effects · From $199/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View AOD-9604 →Important distinctions about research-grade AOD-9604:
- Not manufactured to pharmaceutical standards
- May not undergo the same sterility and purity testing as compounded medications
- Not intended for injection into humans
- Purchasing research peptides for personal use introduces legal and safety risks
Athletic and Anti-Doping Regulations
AOD-9604 has a specific history with anti-doping bodies. The World Anti-Doping Agency (WADA) previously investigated AOD-9604 in connection with sports doping cases. Key points for athletes:
- WADA has classified growth hormone fragments under its prohibited substances list in certain categories.
- USADA (United States Anti-Doping Agency) enforces WADA regulations for US athletes.
- Athletes subject to drug testing should assume AOD-9604 is prohibited unless they have confirmed otherwise with their specific governing body.
- The peptide gained attention in 2013 during the Australian Football League doping scandal.
State-Level Regulations
Individual US states may impose additional restrictions on compounded medications and peptide therapies beyond federal regulations. Some states have stricter compounding pharmacy oversight, while others may have specific rules about which substances can be compounded within their jurisdiction. Check with your state board of pharmacy for local regulations affecting AOD-9604 availability.
GRAS Status Clarification
AOD-9604 has received Generally Recognized as Safe (GRAS) status from the FDA as a food ingredient at specific low doses. This GRAS determination applies only to oral ingestion as a dietary supplement ingredient, not to injectable use. The GRAS status doesn't constitute approval for injection or therapeutic use.
Frequently Asked Questions
Is AOD-9604 a controlled substance?
No. AOD-9604 isn't listed as a controlled substance by the DEA. It doesn't appear on any schedule of the Controlled Substances Act. But its availability for therapeutic use is restricted by FDA compounding regulations rather than controlled substance scheduling.
Can I get AOD-9604 from a compounding pharmacy?
Availability depends on the FDA's current regulatory stance regarding AOD-9604 compounding. The FDA has raised concerns about compounding this peptide due to insufficient safety data. Check with your prescribing physician and compounding pharmacy for the most current availability status.
Is AOD-9604 banned for athletes?
Athletes subject to WADA or USADA testing should treat AOD-9604 as a prohibited substance. Growth hormone fragments fall under banned categories in most anti-doping frameworks. Always verify with your specific sport's governing body before using any peptide.
Does GRAS status mean AOD-9604 is FDA approved?
No. GRAS (Generally Recognized as Safe) status applies only to AOD-9604 as a food ingredient at specific oral doses. It doesn't constitute FDA approval for injectable or therapeutic use. The two designations are entirely separate regulatory categories.
What are the penalties for illegally selling AOD-9604 for human use?
Selling unapproved drugs or misbranded substances for human use can result in FDA enforcement actions including warning letters, injunctions, seizures, and criminal prosecution. Companies and individuals marketing AOD-9604 for therapeutic use without proper authorization risk significant legal consequences.
Ready when you are
AOD-9604
Fat-targeting fragment without growth hormone side effects · From $199/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View AOD-9604 →